Elekta AB (publ) (OTCMKTS:EKTAY) Sees Large Decline in Short Interest

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) was the target of a large decline in short interest in May. As of May 31st, there was short interest totalling 100 shares, a decline of 99.5% from the May 15th total of 20,600 shares. Based on an average daily trading volume, of 14,900 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company's stock are sold short.

Analyst Upgrades and Downgrades

Separately, Danske cut shares of Elekta AB (publ) to a "hold" rating in a report on Tuesday, June 3rd.

Elekta AB (publ) Trading Up 3.2%

Elekta AB (publ) stock traded up $0.16 during mid-day trading on Thursday, hitting $5.14. The company's stock had a trading volume of 4,087 shares, compared to its average volume of 16,623. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.05 and a quick ratio of 0.81. Elekta AB has a 12 month low of $4.36 and a 12 month high of $7.13. The business has a 50 day moving average price of $5.04 and a 200-day moving average price of $5.44. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 20.56 and a beta of 1.22.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. The firm had revenue of $503.22 million for the quarter, compared to analysts' expectations of $507.19 million. As a group, analysts forecast that Elekta AB will post 0.36 EPS for the current year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.